{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:31Z","timestamp":1792190611446,"version":"4.4.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC2020_INFETT_FIERABRACCI"],"award-info":[{"award-number":["RC2020_INFETT_FIERABRACCI"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC IG 21814"],"award-info":[{"award-number":["AIRC IG 21814"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Carcinomas evade the host immune system by negatively modulating CD4+ and CD8+ T effector lymphocytes through forkhead box protein 3 (FOXP3) positive T regulatory cells\u2019 increased activity. Furthermore, interaction of the programmed cell death 1 (PD1) molecule and its ligand programmed cell death ligand 1 (PDL1) inhibits the antitumor activity of PD1+ T lymphocytes. Immunotherapy has become a powerful strategy for tailored cancer patients\u2019 treatment both in adult and pediatric patients aiming to generate potent antitumor responses. Nevertheless, immunotherapies can generate autoimmune responses. This study aimed to investigate the potential effect of the transformation-related protein 53 (p53) reactivation by a peptide-based inhibitor of the MDM2\/MDM4 heterodimer (Pep3) on the immune response in a solid cancer,<jats:italic>i.e.<\/jats:italic>, thyroid carcinoma frequently presenting with thyroid autoimmunity. In peripheral blood mononuclear cell of thyroid cancer patients, Pep3 treatment alters percentages of CD8+ and CD4+ T regulatory and CD8+ and CD4+ T effector cells and favors an anticancer immune response. Of note that reduced frequencies of activated CD8+ and CD4+ T effector cells do not support autoimmunity progression. In evaluating PD1 expression under p53 activation, a significant decrease of activated CD4+PD1+ cells was detected in thyroid cancer patients, suggesting a defective regulation in the initial activation stage, therefore generating a protective condition toward autoimmune progression.<\/jats:p>","DOI":"10.3389\/fimmu.2021.728381","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T02:02:07Z","timestamp":1630720927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity"],"prefix":"10.3389","volume":"12","author":[{"given":"Andrea","family":"Arena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Stigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Belcastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Manuela","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Assenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fierabracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02374","article-title":"Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression","volume":"9","author":"Gianchecchi","year":"2018","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1936","article-title":"Cancer Despite Immunosurveillance: Immunoselection and Immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.37841","article-title":"P53 Controls Autoimmune Arthritis via STAT-Mediated Regulation of the Th17 Cell\/Treg Cell Balance in Mice","volume":"65","author":"Park","year":"2013","journal-title":"Arthritis Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4787","article-title":"PD-1: Dual Guard for Immunopathology","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer Immunotherapies Targeting the PD-1 Signaling Pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J Biomed Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor Antigen-Specific CD8 T Cells Infiltrating the Tumor Express High Levels of PD-1 and Are Functionally Impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 Expression Balance Between Effector and Regulatory T Cells Predicts the Clinical Efficacy of PD-1 Blockade Therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellimm.2012.07.001","article-title":"Tumor-Infiltrating Regulatory T Cells Delineated by Upregulation of PD-1 and Inhibitory Receptors","volume":"278","author":"Park","year":"2012","journal-title":"Cell Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery Technologies for Cancer Immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02023","article-title":"Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab Plus Ipilimumab in Advanced Melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and Ipilimumab Versus Ipilimumab in Untreated Melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17121975","article-title":"The Double Role of P53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target","volume":"17","author":"Fierabracci","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472","article-title":"Targeting the MDM2\/MDM4 Interaction Interface as a Promising Approach for P53 Reactivation Therapy","volume":"75","author":"Pellegrino","year":"2015","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402309","article-title":"Structure of the MDM2\/MDMX RING Domain Heterodimer Reveals Dimerization Is Required for Their Ubiquitylation in Trans","volume":"15","author":"Linke","year":"2008","journal-title":"Cell Death Differ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.07.021","article-title":"Mdmx Enhances P53 Ubiquitination by Altering the Substrate Preference of the Mdm2 Ubiquitin Ligase","volume":"583","author":"Okamoto","year":"2009","journal-title":"FEBS Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.113.10.1661","article-title":"The P53\/P63\/P73 Family of Transcription Factors: Overlapping and Distinct Functions","volume":"113","author":"Levrero","year":"2000","journal-title":"J Cell Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic Functions of the Tumour Suppressor P53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.99","article-title":"Emerging Roles of P53 and Other Tumour-Suppressor Genes in Immune Regulation","volume":"16","author":"Mu\u00f1oz-Fontela","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.2014012193","article-title":"Role of P53 in Systemic Autoimmune Diseases","volume":"34","author":"Takatori","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0228296","DOI":"10.1371\/journal.pone.0228296","article-title":"Effect of P53 Activation Through Targeting MDM2\/MDM4 Heterodimer on T Regulatory and Effector Cells in the Peripheral Blood of Type 1 Diabetes Patients","volume":"15","author":"Pellegrino","year":"2020","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/a-0648-4593","article-title":"Thyroid Autoimmunity and Thyroid Cancer - The Pathogenic Connection: A 2018 Update","volume":"50","author":"Nagayama","year":"2018","journal-title":"Horm Metab Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","article-title":"New Therapies for Advanced Thyroid Cancer","volume":"11","author":"Laha","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2011.058","article-title":"Genotypes of P53 Codon 72 Correlate With Age at Onset of Type 1 Diabetes in a Sex-Specific Manner","volume":"24","author":"Manca Bitti","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160922584","article-title":"Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients With Insulin-Dependent Diabetes Mellitus","volume":"16","author":"Perri","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e110755","DOI":"10.1371\/journal.pone.0110755","article-title":"Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis","volume":"9","author":"Gianchecchi","year":"2014","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0210839","DOI":"10.1371\/journal.pone.0210839","article-title":"Identification and Functional Characterization of CD8+ T Regulatory Cells in Type 1 Diabetes Patients","volume":"14","author":"Pellegrino","year":"2019","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and During Interleukin-2 Therapy","volume":"6","author":"Churlaud","year":"2015","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in Regulatory T Cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-008-0322-6","article-title":"Analysis of Human MDM4 Variants in Papillary Thyroid Carcinomas Reveals New Potential Markers of Cancer Properties","volume":"86","author":"Prodosmo","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ng1093","article-title":"The Codon 72 Polymorphic Variants of P53 Have Markedly Different Apoptotic Potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-117892","article-title":"Hashimotos Thyroiditis Is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults","volume":"49","author":"Liu","year":"2017","journal-title":"Horm Metab Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.597","article-title":"Cancer Risk in Patients With Hashimoto\u2019s Thyroiditis: A Nationwide Cohort Study","volume":"109","author":"Chen","year":"2013","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12603","article-title":"Programmed Death-Ligand 1 Expression in Gastric Adenocarcinoma Is a Poor Prognostic Factor in a High CD8+ Tumor Infiltrating Lymphocytes Group","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression Profile of Immune Checkpoint Genes and Their Roles in Predicting Immunotherapy Response","volume":"19","author":"Hu","year":"2020","journal-title":"Brief Bioinform"},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1-PD-L Pathway in Immunological Tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80089-8","article-title":"Development of Lupus-Like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1117","article-title":"High PD-1\/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1\/PD-L1 Treatment","volume":"80","author":"S\u00e1nchez-Magraner","year":"2020","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03235-6","article-title":"Lipid Signalling Enforces Functional Specialization of Treg Cells in Tumours","volume":"591","author":"Lim","year":"2021","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","article-title":"P53 Represses the Mevalonate Pathway to Mediate Tumor Suppression","volume":"176","author":"Moon","year":"2019","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12942","article-title":"Ultraviolet Irradiation Promotes FOXP3 Transcription via P53 in Psoriasis","volume":"25","author":"Zhang","year":"2016","journal-title":"Exp Dermatol"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.153.2.712","article-title":"NF-Kappa B Regulates IL-1 Beta Transcription Through a Consensus NF-Kappa B Binding Site and a Nonconsensus CRE-Like Site","volume":"153","author":"Cogswell","year":"1994","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T16:01:29Z","timestamp":1673193689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2021.728381"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.728381","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"article-number":"728381"}}